Literature DB >> 28496772

The Impact of Atrial Fibrillation Ablation on Quality of Life.

Jacob Pontoppidan1.   

Abstract

Quality of life (QoL) is a very important endpoint in trials reporting the efficacy of catheter ablation in patients with atrial fibrillation (AF). It has been shown that AF ablation significantly improves the QoL, but recent studies question the usefulness of the most used generic QoL instrument in AF patients. The complexity of the disease makes it mandatory to employ disease specific instruments in the assessment of QoL. This paper reviews the current knowledge of various QoL instruments, including the limitations and pitfalls, and the impact of AF ablation on the QoL.

Entities:  

Year:  2012        PMID： 28496772      PMCID： PMC5153212          DOI： 10.4022/jafib.602

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  28 in total

1.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function.

Authors:  Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia
Journal:  Pacing Clin Electrophysiol       Date:  2006-09       Impact factor: 1.976

4.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.

Authors:  Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Rong Bai; Agnes Pump; Pasquale Santangeli; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-04-03       Impact factor: 24.094

5.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

6.  Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.

Authors:  Fernando Arribas; José Miguel Ormaetxe; Rafael Peinado; Nuria Perulero; Patricia Ramírez; Xavier Badia
Journal:  Europace       Date:  2010-01-06       Impact factor: 5.214

7.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life.

Authors:  Jacob Pontoppidan; Jens Cosedis Nielsen; Steen Hvitfeldt Poulsen; Peter Steen Hansen
Journal:  Pacing Clin Electrophysiol       Date:  2009-06       Impact factor: 1.976

Review 9.  Quality of life in atrial fibrillation: measurement tools and impact of interventions.

Authors:  Matthew R Reynolds; Ethan Ellis; Peter Zimetbaum
Journal:  J Cardiovasc Electrophysiol       Date:  2008-02-05

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.